Drug Shortage Report for APO-ALENDRONATE/VITAMIN D3

Last updated on 2021-01-20 History
Report ID 128922
Drug Identification Number 02454475
Brand name APO-ALENDRONATE/VITAMIN D3
Common or Proper name ALENDRONATE/VITAMIN D3
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID VITAMIN D3
Strength(s) 70MG 5600UNIT
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 4 BLS
ATC code M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-11-20
Estimated end date 2021-03-26
Actual end date
Shortage status Actual shortage
Updated date 2021-01-20
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-01-20 French Compare
v5 2021-01-20 English Compare
v4 2021-01-15 French Compare
v3 2021-01-15 English Compare
v2 2020-11-26 French Compare
v1 2020-11-26 English Compare